Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn C Hartmann

Showing results (101-110 of 147) with videos related to

Pageof 15
Sort By:
Breast Cancer Research and Treatment|February 6, 2016
Natural history of age-related lobular involution and impact on breast cancer riskDerek C Radisky, Daniel W Visscher, Ryan D Frank, et al.
Cancer Research|June 19, 2008
An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancerKimberly R Kalli, Christopher J Krco, Lynn C Hartmann, et al.
International Journal of Molecular Epidemiology and Genetics|June 21, 2011
Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcomePrema Peethambaram, Brooke L Fridley, Robert A Vierkant, et al.
Breast Cancer Research and Treatment|February 26, 2008
Breast cancer risk in women with radial scars in benign breast biopsiesJena C Berg, Daniel W Visscher, Robert A Vierkant, et al.
Breast Cancer Research : BCR|December 21, 2017
Association between mammographic breast density and histologic features of benign breast diseaseKarthik Ghosh, Robert A Vierkant, Ryan D Frank, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2008
Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancerThomas A Sellers, Yifan Huang, Julie Cunningham, et al.
Breast Cancer Research and Treatment|July 29, 2017
Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involutionMelody L Stallings-Mann, Ethan P Heinzen, Robert A Vierkant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2010
A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102Lavakumar Karyampudi, Courtney Formicola, Courtney L Erskine, et al.
Gynecologic Oncology|January 27, 2015
Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo ClinicAndrea E Wahner Hendrickson, Kieran M Hawthorne, Ellen L Goode, et al.
Breast Cancer Research and Treatment|August 5, 2016
Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case-control studyJonine D Figueroa, Ruth M Pfeiffer, Louise A Brinton, et al.
Pageof 15

Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
Breast Cancer Research and Treatment|February 6, 2016
Natural history of age-related lobular involution and impact on breast cancer riskDerek C Radisky, Daniel W Visscher, Ryan D Frank, et al.
Cancer Research|June 19, 2008
An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancerKimberly R Kalli, Christopher J Krco, Lynn C Hartmann, et al.
International Journal of Molecular Epidemiology and Genetics|June 21, 2011
Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcomePrema Peethambaram, Brooke L Fridley, Robert A Vierkant, et al.
Breast Cancer Research and Treatment|February 26, 2008
Breast cancer risk in women with radial scars in benign breast biopsiesJena C Berg, Daniel W Visscher, Robert A Vierkant, et al.
Breast Cancer Research : BCR|December 21, 2017
Association between mammographic breast density and histologic features of benign breast diseaseKarthik Ghosh, Robert A Vierkant, Ryan D Frank, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2008
Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancerThomas A Sellers, Yifan Huang, Julie Cunningham, et al.
Breast Cancer Research and Treatment|July 29, 2017
Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involutionMelody L Stallings-Mann, Ethan P Heinzen, Robert A Vierkant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2010
A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102Lavakumar Karyampudi, Courtney Formicola, Courtney L Erskine, et al.
Gynecologic Oncology|January 27, 2015
Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo ClinicAndrea E Wahner Hendrickson, Kieran M Hawthorne, Ellen L Goode, et al.
Breast Cancer Research and Treatment|August 5, 2016
Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case-control studyJonine D Figueroa, Ruth M Pfeiffer, Louise A Brinton, et al.
Pageof 15